Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $2.17 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.